Following an update on its Canadian clinics business, Raymond James analyst Michael W. Freeman remains bullish on WELL Health Technologies (WELL Health Technologies Stock Quote, Chart, News, Analysts, Financials TSX:WELL). On July 8th, WELL announced that its Canadian clinics business was expanding rapidly, expected to post more than $450-million in revenue in 2025, which would […]
Following a sizeable acquisition, Paradigm Capital analyst Daniel Rosenberg has raised his price target on VitalHub (VitalHub Stock Quote, Chart, News, Analysts, Financials TSX:VHI). On July 7th, VHI announced it had acquired Kingston-based healthcare software player Novari for $43.6-million. “We have watched the success of Novari in the Canadian landscape for over a decade, and […]
Share
Tweet
Share
